InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: FatCatz post# 10358

Monday, 07/06/2020 6:32:59 PM

Monday, July 06, 2020 6:32:59 PM

Post# of 16703
Great...
Sharp eyes, cant believe we all missed this. Seems to indicate real movements in Canada and with the USFDA already 'in work'. Fills in this question about CRO work for AGN investors.
We know the Philippines, Australia will be managed by Novotech, Canada and USFDA by GVI which leaves E Eu/Romania for the Multinational Trials. Dr Williams may have those connections in work too.
Sad for Bellus's not reaching their statistical goal but this leaves the "NDMA receptor antagonist(?)" affected with Ifenprodil as a key research target. Good for AGN, IMO.
I doubt we will hear updates from this June 11 news or the efforts these two CROs' do. But the ducks should be lined up soon now, IMO...
Maybe the international contributions and recruitments of sites and patients will go much faster for AGN's Multinational Trials now than was thought before you pointed out the Canadian CRO, GVI was handling North America...

Novotech also works with India, another country suffering this later phase of infections. Maybe?. Didn't Dr Wiliams say he had made an Ethics presentation and concept thesis that they could present to prospect hospitals / Countries?...